by The global next-generation sequencing market size is forecasted to reach from US$ 6.37 billion in 2021 to US$ 24.4 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 16.1% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.
The next-generation sequencing market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1454
The procedure of DNA sequencing known as next-generation sequencing determines the exact arrangement of nucleotides within a DNA molecule. The next-generation sequencer creates a million DNA molecules and RNA sequences per second, allowing for rapid sequencing. The high-throughput sequencing is referred to as next-generation sequencing (NSG).
The use of next-generation sequencing in the development of customized therapeutics at the generic level is expected to increase demand for next-generation sequencing in the future years. The increased applications of next-generation sequencing (NSG) in chronic diseases and oncology are projected to drive the next-generation sequencing market.
| Report Coverage | Details |
| Market Size In 2021 | USD 6.37 Billion |
| Growth Rate | CAGR of 16.1% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Application, Technology, Region |
Competitive Landscape Analysis:
Some of the leading companies operating in the next-generation sequencing market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- BGI Group
- F. Hoffmann-La Roche AG
- Pacific Biosciences of California Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Precigen Inc.
- Illumina Inc.
- Qiagen N.V.
- PerkinElmer Inc.
- PierianDx Inc.
Market Dynamics
Drivers – Rising research and development activities
The increasing research and development activities for developing therapies used in the treatment of genetic disorders will increase the demand for next generation sequencing methods over the course of the study. Increased investments in research and development activities, as well as an increase in the number of studies on the treatment of genetic disorders in individuals, will create a massive market demand. Governments in developed economies have implemented a number of policies and enacted legislation to encourage scientists and researchers to find solutions to chronic and rare diseases. Thus, the rising research and development activities are driving the growth of next-generation sequencing (NGS) market.
Restraints – Lack of clinical validation
Due to a lack of scientific evidence, the clinical validity of direct-to-consumer genetic tests has been consistently questioned. This has an adverse effect on the commercialization of predisposition tests. Single-gene testing by Sanger sequencing is used in direct-to-consumer tests because it is the most cost-effective method for studying inherited disorders with low phenotypic and genetic heterogeneity. With the increase in heterogeneity, it is more efficient to use next-generation sequencing (NGS) panels to study multiple targets at the same time. Furthermore, direct-to-consumer genetic tests have limited accuracy and frequently produce false-positive or false-negative results, which can have a negative impact on consumer health and cause emotional and mental distress. This has compelled regulatory authorities to scrutinize vendors and mandate the disclosure of risk information and instructions.
Opportunities – Advancement in next-generation sequencing (NGS) platforms
The continuous technological advancements in sequencers have enabled the introduction of efficient, portable, and simple-to-use of next-generation sequencing (NGS) platforms capable of providing rapid and accurate results and boasting improved turnaround times. The launch of next-generation sequencing (NGS) technologies provides key market players with a benefit; as a result, the market companies are highly investing on research and development of new technologies to drive the market growth. As a result, the advancement in of next-generation sequencing (NGS) platforms is creating lucrative opportunities for the growth of the market.
Challenges – End user budget constraints
In developing countries, the academic research is mostly reliant on outside financing. Despite private and government sector attempts to offer funding for research around the world, numerous research and academic institutes have budget limits when it comes to the purchase and use of innovative and high-priced equipment and technology. As a result, advanced research facilities in academic and research institutes in underdeveloped countries are being installed at a slow pace. Thus, end user budget is a big challenge for the market growth.
Report Highlights
- Based on the product, the consumables segment dominated the global next-generation sequencing market in 2020 with highest market share. The consumables have a short lifespan, resulting in a high replacement rate, which drives increasing demand for them. The consumables are also ordered in large quantities from many manufacturers because it has been demonstrated to be cost-effective method for researchers and scientists to increase market value.
- Based on the application, the biomarker and cancer segment dominated the global next-generation sequencing market in 2020 with highest market share. Due to an increase in the occurrence of different kind of cancers, the global next-generation sequencing market is predicted to develop significantly during the forecast period.
Regional Snapshot
North America is the largest segment for next-generation sequencing market in terms of region. The regional market is driven by the existence of a number of clinical laboratories that employ next-generation sequencing (NGS) to provide genetic testing services. Furthermore, the leading firms in North America are developing and launching new products, which are fueling the next-generation sequencing market growth.
Europe region is the fastest growing region in the next-generation sequencing market. The key market players are increasingly focusing on offering cost-effective next-generation sequencing (NGS) technologies to developing nations in order to meet the demand for genomic therapeutics and whole-genome sequencing for personalized medicine.
Segments Covered in the Report
By Product
- Consumables Platforms
- Services and Nerve Blockers
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Others
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Others
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Clinical Research
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global next-generation sequencing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for next-generation sequencing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1454
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Next Generation Sequencing Market
5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Next Generation Sequencing Market, By Product
8.1. Next Generation Sequencing Market, by Product Type, 2021-2030
8.1.1. Consumables Platforms
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services and Nerve Blockers
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Next Generation Sequencing Market, By Application
9.1. Next Generation Sequencing Market, by Application, 2021-2030
9.1.1. Diagnostics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Biomarkers and Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Reproductive Health
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Personalized Medicine
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Agriculture and Animal Research
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Next Generation Sequencing Market, By Technology Type
10.1. Next Generation Sequencing Market, by Technology Type, 2021-2030
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Next Generation Sequencing Market, By End User Type
11.1. Next Generation Sequencing Market, by End User Type, 2021-2030
11.1.1. Academic and Research Centers
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Hospitals and Clinics
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Clinical Research
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
Chapter 13. Company Profiles
13.1. BGI Group
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pacific Biosciences of California Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Precigen Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Qiagen N.V.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PierianDx Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1454
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
